Table 2. Impact of disease-related clinical factors on the extent of drug adherence .
DA, drug adherence
| Clinical factors related to the disease | High DA (n=93) | Medium DA (n=117) | Low DA (n=79) | P value |
| Regularly visit endocrinologist | ||||
| Yes | 72 (77.4%) | 82 (70.1%) | 25 (31.6%) | <0.00001 |
| No | 21 (22.5%) | 35 (29.9%) | 54 (68.3%) | |
| Knowledge given about the condition by the managing endocrinologist | ||||
| Yes | 45 (48.3%) | 72 (61.5%) | 37 (46.8%) | 0.06 |
| No | 48 (51.6%) | 45 (38.4%) | 42 (53.1%) | |
| Knowledge given about the medication by the managing endocrinologist | ||||
| Yes | 68 (73.1%) | 69 (58.9%) | 24 (30.3%) | <0.00001 |
| No | 25 (26.8%) | 48 (41.0%) | 55 (69.6%) | |
| Need assistance taking medication | ||||
| Yes | 25 (26.8%) | 34 (29.1%) | 48 (60.7%) | <0.00001 |
| No | 68 (73.1%) | 83 (70.9%) | 31 (39.2%) | |
| Medication affordability | ||||
| Yes | 55 (59.2%) | 84 (71.7%) | 29 (36.7%) | <0.00001 |
| No | 38 (40.8%) | 33 (28.2%) | 50 (63.3%) | |
| Medication accessibility | ||||
| Yes | 52 (55.9%) | 67 (57.2%) | 35 (44.3%) | 0.16 |
| No | 41 (44.1%) | 50 (42.7%) | 44 (55.7%) | |
| Busy work schedule | ||||
| Yes | 25 (26.8%) | 53 (45.3%) | 46 (58.2%) | 0.0001 |
| No | 68 (73.1%) | 64 (54.7%) | 33 (41.7%) | |
| Avoid medication when symptomatic relief | ||||
| Yes | 14 (15.1%) | 41 (35.1%) | 60 (75.9%) | <0.00001 |
| No | 79 (84.9%) | 76 (64.9%) | 19 (24.1%) | |
| Avoid medication due to side affects | ||||
| Yes | 11 (11.8%) | 19 (16.2%) | 20 (25.3%) | 0.06 |
| No | 82 (88.2%) | 98 (83.7%) | 59 (74.7%) | |